Supplements

Why Is My IGF-1 Borderline High or Low?

A borderline IGF-1 result sits in a frustrating grey zone — not flagged by most doctors, yet quietly linked to fatigue, body composition shifts, and metabolic risk. Understanding what pushes IGF-1 out of its optimal range is the first step toward doing something useful about it.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
IGF-1growth hormoneblood testhormonal healthpersonalized supplements
Why Is My IGF-1 Borderline High or Low?

Why Is My IGF-1 Borderline High or Low?

For most adults, a borderline IGF-1 means your growth hormone axis is under mild stress — usually from poor sleep, low protein intake, insulin resistance, or micronutrient gaps. It rarely signals disease on its own, but it does reflect something in your physiology that deserves attention. The exception is anyone with a pituitary disorder or active metabolic disease, who needs specialist evaluation before acting on supplements or lifestyle changes.

---

What Is IGF-1 and Why Does It Matter?

Insulin-like Growth Factor 1 (IGF-1) is a peptide hormone produced primarily in the liver in response to growth hormone (GH) signaling. It mediates most of GH's anabolic effects — muscle protein synthesis, bone density maintenance, glucose uptake, and cognitive repair. Unlike GH itself, which pulses throughout the day, IGF-1 is relatively stable in the bloodstream, making it a far more reliable marker of overall GH axis activity.

Reference ranges vary by lab and age, but most functional medicine practitioners consider 150–300 ng/mL optimal for adults between 20 and 60. Values above 300 ng/mL or below 100 ng/mL warrant medical follow-up. "Borderline" typically means you're drifting toward either edge — say, 110–140 ng/mL on the low side, or 275–310 ng/mL trending upward — without crossing into clinical territory.

IGF-1 also matters for longevity. Higher-than-optimal IGF-1 has been associated with increased cancer risk in some cohorts (Renehan et al., The Lancet 2004; PMID: 15016485), while chronically low IGF-1 is associated with sarcopenia, cardiovascular risk, and cognitive decline (Cappola et al., Journal of Clinical Endocrinology & Metabolism 2003; PMID: 12679442). That tension between too much and too little is exactly why the borderline zone matters.

---

IGF-1 Blood Test: What the Numbers Actually Tell You

The IGF-1 blood test is a serum measurement, usually drawn in the morning after a normal overnight fast. It doesn't require special timing the way a GH stimulation test does, which is part of its clinical utility.

IGF-1 Range (Adults 20–60)Interpretation
< 100 ng/mLLow — investigate GH deficiency, malnutrition, liver disease
100–140 ng/mLBorderline low — common with poor sleep, low protein, zinc deficiency
140–300 ng/mLGenerally optimal for most adults
300–350 ng/mLBorderline high — monitor; assess insulin resistance and diet
> 350 ng/mLElevated — requires endocrinology referral

One underappreciated issue: standard serum IGF-1 doesn't tell you about IGF binding proteins (IGFBPs), particularly IGFBP-3, which regulates how much free IGF-1 actually reaches your tissues. Some practitioners order an IGF-1 to IGFBP-3 ratio for a fuller picture. If your IGF-1 is borderline low but your IGFBP-3 is also low, the bioavailable fraction may be more impaired than the number suggests.

Common reasons for a borderline-low result include inadequate dietary protein, zinc deficiency (zinc is a co-factor for GH receptor signaling), chronic sleep debt, and caloric restriction. If you're unsure whether micronutrient gaps are playing a role, reviewing your zinc status alongside an immune and mineral panel is a sensible place to start.

Common reasons for a borderline-high result include high dietary simple sugar load, elevated insulin, excess growth hormone secretagogue use, and obesity-associated GH resistance — a paradox where GH levels are elevated but IGF-1 tissue signaling is blunted.

---

Symptoms of Low IGF-1

Borderline low IGF-1 rarely announces itself dramatically. The symptoms tend to be vague, cumulative, and easy to attribute to aging or stress:

  • Fatigue and low exercise tolerance — IGF-1 is required for mitochondrial biogenesis and muscle protein synthesis; without adequate signaling, recovery is slow.
  • Loss of lean muscle mass — Even with consistent training, muscle-building stalls when IGF-1 is insufficient.
  • Increased body fat, especially visceral — GH and IGF-1 promote lipolysis; low levels tip the balance toward fat storage.
  • Brain fog and difficulty concentrating — IGF-1 receptors are dense in the hippocampus; the hormone supports neurogenesis and synaptic plasticity (Duan et al., Journal of Neuroscience 1999; PMID: 10559416).
  • Low mood or mild depression — IGF-1 interacts with serotonergic pathways and neurotrophin signaling.
  • Reduced bone density markers — IGF-1 stimulates osteoblasts; low levels over years contribute to osteopenia risk.
  • Poor skin elasticity and slow wound healing

These symptoms overlap considerably with low testosterone, thyroid hypofunction, and iron deficiency anemia — which is why a borderline IGF-1 result should almost always be interpreted alongside a broader panel. If you're also tracking blood sugar markers, it's worth understanding what a borderline A1C means for your metabolic health, since insulin resistance and GH axis dysfunction often travel together.

---

Symptoms of High IGF-1

Borderline-high IGF-1 is less common in the general population but increasingly recognized in people following aggressive muscle-building protocols or high-calorie Western diets:

  • Joint pain and swelling — Excess IGF-1 promotes soft tissue growth, which can manifest as joint discomfort or carpal tunnel-like symptoms.
  • Increased skin tags and coarse skin texture — Classic signs of excess GH/IGF-1 signaling.
  • Fatigue from anabolic overdrive — Paradoxically, chronically elevated anabolic signaling without adequate recovery leads to systemic fatigue.
  • Elevated fasting glucose or insulin resistance — IGF-1 and insulin share receptor pathways; excess IGF-1 can contribute to glucose dysregulation.
  • Elevated blood pressure — High IGF-1 activates the renin-angiotensin system and promotes sodium retention (Colao et al., Endocrine Reviews 2004; PMID: 15233916).
  • Accelerated cell turnover — The main long-term concern is that persistently high IGF-1 is associated with higher rates of certain hormone-sensitive cancers, particularly prostate and premenopausal breast cancer in large epidemiological studies (Renehan et al., The Lancet 2004; PMID: 15016485).

If you're managing borderline-high IGF-1 alongside elevated blood pressure, those two findings together deserve coordinated evaluation — lab tests for high blood pressure can help you build a more complete picture before making supplement or dietary decisions.

---

What Causes Borderline IGF-1? The Most Common Drivers

Sleep and Circadian Rhythm

Approximately 70% of GH secretion occurs during slow-wave sleep (SWS), specifically in the first few hours after sleep onset. Chronic sleep restriction — even modest, like averaging 6 hours instead of 8 — meaningfully suppresses GH pulsatility and downstream IGF-1 production. A controlled trial found that one week of sleep restriction to 5 hours per night reduced IGF-1 by approximately 15–20% in healthy young men (Van Cauter et al., Sleep 2000; PMID: 10947027).

This is often the most correctable driver of borderline-low IGF-1 and the first place to look.

Protein and Caloric Intake

IGF-1 synthesis in the liver is acutely sensitive to protein availability. Studies in both athletes and sedentary populations confirm that protein intakes below 0.8 g/kg/day reliably suppress IGF-1, while intakes of 1.2–1.6 g/kg/day are associated with optimal levels. Total caloric restriction also suppresses IGF-1 — a mechanism that likely underlies the longevity effects of caloric restriction in animal models.

Zinc and Micronutrient Status

Zinc is a cofactor for GH receptor binding and IGF-1 signal transduction. Suboptimal zinc status — which may not register as frank deficiency on a standard serum zinc test — has been shown to reduce IGF-1 in both children and adults. Correcting zinc status can partially restore IGF-1 within 8–12 weeks in zinc-insufficient individuals.

Similarly, magnesium and vitamin D3 influence insulin sensitivity, which indirectly affects the GH-IGF-1 axis. If you're seeing borderline IGF-1 alongside low magnesium markers, the biochemistry behind low RBC magnesium and its systemic effects is worth reviewing in depth.

Insulin Resistance

Insulin resistance creates a paradox: GH secretion is often elevated (due to impaired IGF-1 feedback), yet hepatic IGF-1 output is blunted because insulin signaling is required for the liver to respond to GH. The result is high GH, low IGF-1, and high IGFBP-1 — a pattern increasingly common in people with metabolic syndrome.

Liver Function

Since the liver produces roughly 75% of circulating IGF-1, any hepatic impairment — even mild, subclinical liver stress — can reduce IGF-1 output. Non-alcoholic fatty liver disease (NAFLD), which affects an estimated 25% of adults globally, is associated with measurably lower IGF-1 levels independent of other metabolic variables.

---

How to Naturally Support Optimal IGF-1 Levels

The evidence-based levers for borderline IGF-1 — both low and high — cluster into a few categories:

To support borderline-low IGF-1:

  1. Prioritize 7.5–9 hours of sleep, with consistent sleep and wake times to protect SWS architecture.
  2. Increase protein intake to 1.2–1.6 g/kg/day, emphasizing leucine-rich sources (whey, eggs, meat, legumes).
  3. Resistance train 3–4 times per week — acute GH pulses following heavy compound lifts reliably stimulate IGF-1 production.
  4. Correct zinc insufficiency (target serum zinc 85–110 µg/dL, or use RBC zinc if available).
  5. Optimize vitamin D3 status to 50–70 ng/mL 25(OH)D.
  6. Address insulin resistance through reduced refined carbohydrate intake and improved cardiorespiratory fitness.

To moderate borderline-high IGF-1:

  1. Reduce total caloric surplus and limit high-glycemic foods.
  2. Increase dietary fiber and cruciferous vegetables, which may modulate IGF-1 through sex hormone binding globulin pathways.
  3. Consider whether any supplements or protocols you're using (creatine in megadoses, certain amino acid stacks, or peptides) are contributing.
  4. Monitor with repeat testing every 6 months.

---

What This Means for Your Formula

IGF-1 optimization sits at the intersection of sleep, nutrition, micronutrient status, and metabolic health — which is why a one-size-fits-all supplement stack rarely moves the needle. Ones analyzes your bloodwork, wearable sleep data, and health history together to identify which of these levers is actually limiting your GH axis.

For someone with borderline-low IGF-1 driven by zinc insufficiency, Ones may include Zinc (as zinc bisglycinate, 25–30 mg) at a dose calibrated to bring RBC zinc into range — not just serum zinc, which is a less sensitive marker. The formula would not simply add a generic zinc tablet; it would account for copper status (since high-dose zinc competes with copper absorption) and titrate accordingly.

For someone showing poor sleep architecture on wearable data alongside a borderline-low IGF-1, Ones may include Magnesium Glycinate (from the proprietary Magnesium Complex blend) to support GABA-ergic signaling and slow-wave sleep depth — a mechanism supported by clinical trial data in magnesium-insufficient adults (Abbasi et al., Journal of Research in Medical Sciences 2012; PMID: 23853635).

Where vitamin D3 deficiency is contributing to impaired insulin signaling and downstream IGF-1 suppression, Vitamin D3 + K2 (MK-7) in Ones formulas is dosed to therapeutic ranges (typically 2,000–5,000 IU D3 with 90–180 mcg MK-7) — not the nominal 400–800 IU found in most multivitamins.

The critical difference from a generic protocol is that Ones doesn't add all three of these ingredients by default. Each capsule in a 6- or 9-capsule daily plan is chosen based on your specific findings. If your zinc is fine, that slot goes to something your data actually supports.

---

Key Takeaways

  • A borderline IGF-1 result — low or high — is almost never a standalone finding; it reflects upstream drivers including sleep quality, protein intake, zinc status, insulin sensitivity, and liver function.
  • Borderline-low IGF-1 commonly presents as fatigue, slow muscle recovery, brain fog, and body composition changes that look like aging but may be correctable.
  • Borderline-high IGF-1 is associated with joint discomfort, elevated blood pressure, and long-term cancer risk considerations — not just muscle growth.
  • The IGF-1 blood test is most useful when paired with IGFBP-3, fasting insulin, zinc, vitamin D, and liver enzyme markers for a complete mechanistic picture.
  • Sleep is the highest-leverage, most underutilized intervention for borderline-low IGF-1 — 7.5–9 hours of consistent, high-quality sleep can produce measurable recovery in GH pulsatility within weeks.
  • Supplementation should target your specific deficits (zinc, magnesium, vitamin D3) rather than a generic growth hormone support stack; personalized formulas calibrated to your blood data are more likely to move your IGF-1 toward the optimal range than broad-spectrum products.

---

Always consult a qualified healthcare provider before making changes based on a single lab result. IGF-1 interpretation requires clinical context.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading